José M. Moltedo

ORCID: 0000-0003-2014-3095
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Congenital Heart Disease Studies
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac Structural Anomalies and Repair
  • Ethics and bioethics in healthcare
  • Otolaryngology and Infectious Diseases
  • Streptococcal Infections and Treatments
  • Child and Adolescent Health
  • Ion channel regulation and function
  • Cardiac Valve Diseases and Treatments
  • Pericarditis and Cardiac Tamponade
  • Cardiomyopathy and Myosin Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Neuroscience of respiration and sleep
  • ECG Monitoring and Analysis
  • Medical research and treatments
  • Health, Education, and Physical Culture
  • Health and Medical Research Impacts
  • Parkinson's Disease and Spinal Disorders
  • Mitochondrial Function and Pathology
  • Bipolar Disorder and Treatment
  • Nursing care and research

Children's Hospital of Los Angeles
2023

Children's Hospital of Philadelphia
2023

Sanatorio Otamendi y Miroli
2020-2022

University of Buenos Aires
2020

Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
2005-2017

Texas Children's Hospital
2007

Yale University
2002-2007

Baylor College of Medicine
2007

Ochsner Medical Center
2005

Yale New Haven Hospital
2002

The population of patients with congenital heart disease (CHD) is continuously increasing more and reaching adulthood. A significant portion these young adults will suffer from arrhythmias due to the underlying defect itself or as a sequela interventional surgical treatment. medical community encounter an challenge even most individuals complex defects nowadays become adults. Within past 20 years, management has gained remarkable progress including pharmacological treatment, catheter...

10.1093/europace/eux380 article EN EP Europace 2018-03-20

10.1016/j.jtcvs.2006.02.010 article EN publisher-specific-oa Journal of Thoracic and Cardiovascular Surgery 2006-06-01

Left Ventricular Tachycardia in Pediatrics Introduction The aim of this study was to evaluate the clinical presentation and outcomes pediatric patients with ventricular tachycardia (VT) originating from left heart structures. Methods Results This international multicenter retrospective including 152 (age 10.0 ± 5.1 years, 62% male), divided into those fascicular VT (85%, 129/152) nonfascicular LV (15%, 23/152). All had a normal structure or only minor cardiac abnormality. Adenosine largely...

10.1111/jce.12105 article EN Journal of Cardiovascular Electrophysiology 2013-01-25

In view of the increasing complexity both cardiovascular implantable electronic devices (CIEDs) and patients in current era, practice guidelines, by necessity, have become increasingly specific. This document is an expert consensus statement that has been developed to update further delineate indications management CIEDs pediatric patients, defined as ≤21 years age, intended focus primarily on for setting specific disease categories. The also highlights variations between previously...

10.1016/j.ipej.2021.07.005 article EN cc-by-nc-nd Indian Pacing and Electrophysiology Journal 2021-07-29

Objective.To assess the results and adverse events of propranolol therapy in infants younger than 1 year with supraventricular tachycardia.Population methods.Infants documented tachycardia who received oral treatment prophylaxis propranolol.Sex age, associated congenital heart disease, ventricular preexcitation base line electrocardiogram, on-treatment recurrence, were analyzed.Results.A total 107 patients identified.The first event occurred at a median age 190 days.Associated disease was...

10.5546/aap.2020.eng.273 article EN Archivos Argentinos de Pediatria 2020-07-17

Guidelines for the implantation of cardiac implantable electronic devices (CIEDs) have evolved since publication initial ACC/AHA pacemaker guidelines in 1984 [1]. CIEDs to include novel forms pacing, development cardioverter defibrillators (ICDs) and introduction long term monitoring heart rhythm other physiologic parameters. In view increasing complexity both patients, practice guidelines, by necessity, become increasingly specific. 2018, ACC/AHA/HRS published on Evaluation Management...

10.1016/j.ipej.2021.07.006 article EN cc-by-nc-nd Indian Pacing and Electrophysiology Journal 2021-07-29

Fasciculo-ventricular (FV) accessory pathways (AP's) and right anteroseptal (RAS) AP's share similar anatomic locations electrocardiographic characteristics. The objective of this article is to compare these features in children.All patients with manifest pre-excitation who underwent an electrophysiological study were included. defined by the presence HV interval≤32ms a prolongation AH without changes interval, or level during atrial pacing. Three independent blind observers analysed ECG's...

10.1016/j.acmx.2017.05.003 article EN cc-by-nc-nd Archivos de cardiología de México 2017-06-27

intended to provide an exhaustive discussion of the basis for each recommendations, which are further addressed in comprehensive PACES-CIED document, 3 with data easily accessible electronic searches or textbooks. Recommendation-specific supportive textSystemic infections may cause myocardial inflammation infiltration presenting bradycardia complete AV block.In most cases, there is recovery conduction.However, chronic Chagas disease, advanced heart block permanent and pacemaker implantation...

10.4103/0974-2069.322644 article EN Annals of Pediatric Cardiology 2023-01-01
Coming Soon ...